Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation

Idiopathic pulmonary fibrosis is a chronic progressive disease associated with substantial morbidity and mortality despite advances in medical therapy. Increasing evidence suggests that peroxisome proliferator-activated receptors (PPARs) play important roles in the fibrosis-related diseases and thei...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International immunopharmacology 2022-07, Vol.108, p.108728-108728, Article 108728
Hauptverfasser:	Liu, Yuanyuan, Chen, Shuyu, Yu, Li, Deng, Yao, Li, Difei, Yu, Xiu, Chen, Dandan, Lu, Ye, Liu, Shengming, Chen, Rongchang
Format:	Artikel
Sprache:	eng
Schlagworte:	Pemafibrate PPARα Pulmonary fibrosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!